For parallel histologic observations, grafted tissue was fixed in neutral-buffered formalin, processed in a routine manner, and hematoxylin and eosin-stained sections were examined.
Monoclonal Antibodies. The following mouse anti-rat mAb were used; MRC OX6 (36) (Seralab, Crawley Down, United Kingdom) directed against rat MHC class II antigens . This antibody reacts with inbred rat strains of the haplotypes L and N; His 19 (37) reacts with rat MHC class II antigens of the rat strains of haplotype L but not with antigens of rat strains of the N haplotype . The antibody was kindly provided by Dr. Stet (Dept. of Histology, University ofGroningen, The Netherlands) . MRC OX 19 (38) (Seralab, Crawley Down, United Kingdom) reacts with all rat T lymphocytes; W3/25 (39, 40) mainly recognizes T helper cells but also stains a subpopulation of macrophages ; OX8 (39, 41) reacts with T cytotoxic/suppressor cells and a subpopulation of NK cells. ED2 (42) recognizes rat macrophages ; the antibody is directed against membrane antigens of tissue macrophages, and has been described in detail by Dijkstra (Dept . of Histology, Free University, Amsterdam, The Netherlands), who kindly provided the antibody . ART 18 (43) is directed against an antigenic determinant of the IL-2 receptor molecule in rat . The antibody was kindly provided by Dr. Diamantstein (Dept . of Immunology, Klinikum Steglitz, Berlin, Federal Republic of Germany). DB1 (44) , reacting against rat IFN-y was kindly provided by Dr. Van der Meide (Primate Centre, TNO Rijswijk, The Netherlands) . The antibody was prepared by fusing spleen cells from BALB/C mice immunized with recombinant rat IFN-y with the myeloma SP20. The antibody was found to bind to rat IFN-y in an ELISA and to block IFN-y activity in a virus-protection assay. All mAbs were used at saturating dilutions of partially purified immune ascites . Normal kidney tissue from BN and Lewis strain stained negative with mAbs ART18 (anti-IL-2-R) and DB1 (anti-IFN-y). Normal kidney tissue was almost devoid of ED2' cells (macrophages) .
Morphometric Analysis of Tissue Sections. When indicated the cellular infiltration within the grafts was quantified by morphometric analysis according to the method ofMcWhinnie (45) . Cellular infiltration within a section was assessed by point counting using a square grid in the eyepiece of the microscope. The percentage area of each section occupied by cells of a particular antigenic specificity was calculated as follows : Percentage area infiltrated = 100 X (number of positive cells under grid intersections)/(total number of grid intersections) . The accuracy of the technique is proportional to the number ofpoints counted . To maintain a standard error of less than 10%, 4,250 points were counted when density of the infiltrate was less than 10%, 600 points were counted when density of the infiltrate was more than 10% . For point counting a 120 point or 850 point graticule was used, within each section five fields were chosen at random and counted by a magnification of X 400.
Results
Experimental Model for Local Immunosuppression . Allografts treated locally with prednisolone 4 mg/kg body wt/d showed significant prolongation of graft survival (MST, 28 d). As demonstrated in Table 1 , local drug delivery resulted in a mean kidney prednisolone level of 213 ng/kidney and a mean plasma level of the drug of 53 ng/ml. To ascertain that, during intrarenal infusion, local immunosuppression within the graft was responsible for the immunosuppressive effect observed, recipients were treated intraperitoneally with the same dose of prednisolone. Systemic administration of the drug resulted in an MST of 9 d, which was not significantly different from control animals . During intraperitoneal drug delivery the mean plasma prednisolone level was 46 ng/ml . The mean kidney prednisolone level was 126 ng/kidney . These data demonstrate that the systemic plasma level reached during local drug delivery is by itself not sufficiently immunosuppressive to induce graft survival. From these observations it can be concluded that during intrarenal treatment, high kidney prednisolone levels and Untreated animals showed perivascular and interstitial mononuclear cell infiltrates at day 3 after transplantation (Table 11 ). Most of the infiltrating cells were positive for His19, recognizing MHC class II antigens of host type . By day 7 after transplantation, cellular infiltration was clearly increased and intense infiltration of MHC class II-positive cells throughout the kidney was observed associated with marked destruction of renal tissue (Fig. 1 a) .
In animals treated with prednisolone intraperitoneally (MST, 9 d), cellular infiltration was somewhat postponed compared with untreated animals. Eventually, however, at day 7 after transplantation, dense infiltration of MHC class IIpositive cells was observed accompanied by marked destruction of grafted tissue .
The histologic picture of animals treated intrarenally was completely different from untreated and intraperitoneally treated rats (Table II) . Intrarenally treated grafts also showed distinct cellular infiltration with MHC class II-positive cells ( Fig. 1 b) , however, extensive tissue damage and necrosis were not observed .
For further analysis, the composition of cellular infiltrates in untreated and treated animals was investigated (Table III) . At day 7 after transplantation, untreated grafts showed cellular infiltrates composed of T cells and macrophages ( Fig. 1, c and d) . T cells were of T helper as well as T cytotoxic/suppressor phenotype; staining with the mAbs W3/25 and OX8 resulted respectively in a mean area of infiltration of 28 and 29%, which is a ratio of about 1 . Similar levels and patterns of infiltration were found in intraperitoneally treated animals. Grafts treated intrarenally also showed cellular infiltrates composed of T cells Immunohistological studies were performed on grafts removed on day 7 after transplantation. * Data given are mean values ± SD; n = 5. $ Stained simultaneously with W3/25 and OX8.
transplantation the amount of positive cells was significantly increased (Fig. 2, a  and b) . At that time, positive cells were scattered throughout the kidney and were present as isolated cells in the interstitium as well as in cellular infiltrates . The time course of the induction of MHC class II antigens on renal tissue was in accordance with the stainings for IFN-y. On day 3, several foci of MHC class II expression on renal tubules were demonstrated . By the seventh day after transplantation, MHC class II expression was markedly increased, and distinct staining of MHC class II antigens on renal tissue was observed (Fig. 2 c) .
Grafts from animals treated intraperitoneally with prednisolone showed immunohistological stainings on day 7 comparable to untreated rats .
Completely different results however were obtained in animals treated intrarenally (Table II) . Grafts from these rats showed almost no staining for IL-2-R expression and IFN-y, despite the presence of cellular infiltrates (Fig . 3, a-c) . Except for some weak staining on day 7, all stainings with ART 18 and DB1 were negative on day 3 as well as on day 12 after transplantation. These findings correspond well to the observations made in stainings with OX6. On day 3 and day 12 after transplantation all kidneys examined failed to show an increase in MHC class II antigen expression on renal tissue as compared with stainings of normal nongrafted kidneys (Fig . 3d) . Only on day 7 after transplantation were several small foci of MHC class II antigen expression on renal tissue observed . However, compared with intraperitoneally treated or untreated grafts this staining was very weak . From the observations, as summarized in Table 11 , we conclude that intrarenal prednisolone levels interfere with the expression of IL-2-R, the production of IFN-y, and the induction of MHC class 11 antigen expression on renal tissue .
Discussion
In this study we demonstrate that intrarenal prednisolone delivery to rat renal allografts results in high drug levels within the graft combined with low systemic drug levels . Systemic drug levels were, by themselves, not immunosuppressive, and local prednisolone levels within the graft proved to be responsible for the immunosuppressive effect obtained . This experimental model was used to ana- lyze local events in allograft rejection and their response to immunosuppressive therapy . The role oflocal versus systemic immune processes in cellular immune response has been studied in allograft models (30, 32, 46) . These studies report extensive white cell traffic between the lymphoid tissue and the graft in the early days after transplantation . After a time, however, the rejection process becomes independent of the host, and lymphocytes mature and proliferate within the graft, which implies an essential role for local regulatory mechanisms and hence local production of lymphokines .
According to these data, we observed that local treatment of allografts does not prevent the accumulation of activated white cells within the graft, as occurs in the early days after transplantation . White cells positive for MHC class II antigens of host type were equally present in untreated and intrarenally treated rats. Moreover, the composition of the cellular infiltrate in intrarenally treated grafts was comparable to the untreated grafts, except for a lower percentage of infiltrating macrophages . The ratio of W 3/25':OX8+ cells, which is variably reported to be changed during successful systemic immunosuppressive therapy (4, 45, 47, 48) , was not affected by local treatment . These data show that during local treatment the systemic responsiveness of the host is normal . Moreover, the findings confirm that the model of local prednisolone delivery allows the analysis of intragraft events and their response to local immunosuppressive therapy . Local treatment was associated with lack of IL-2-R expression, absence of IFNy, and inhibition of MHC class 11 induction on renal tissue. Inhibition of these intragraft events most likely prevented T cells and macrophages present within the graft from destroying the grafted tissue. Downregulation of MHC class 11 expression on grafted tissue is postulated to be an essential mechanism during successful systemic immunosuppressive therapy (49) . In this study the induction of MHC class 11 expression on renal tissue was inhibited by local treatment, which strongly suggests local regulation of MHC class 11 expression within the graft . Local regulation of MHC class II expression in cellular immune response was also postulated by others (50, 51) . For example, Nathan et al. (51) showed that intradermal injection of IFN-y induced local effects similar to DTH-like hypersensitivity, including MHC class II induction . The physiologic role of the induction of MHC class 11 antigens on grafted tissue is most likely the enhancement of antigen presentation to T helper lymphocytes (15, 16) . Inhibition of MHC class II induction may therefore interfere with the effector mechanisms in graft rejection such as DTH and cell-specific cytotoxicity .
The induction of MHC class II antigens on nonlymphoid tissue is assumed to result from IFN--y (9-11), although recently also non-IFN-y MHC class IIinducing factors have been described (52, 53) . Steroids were reported to inhibit the production of IFN-y (18) , which explains the absence of this lymphokine in the presence of high intrarenal drug levels reached in intrarenally treated grafts . By the inhibition of IFN-y production, prednisolone may indirectly affect the induction of MHC class 11 antigens on grafted tissue.
It has to be noticed that the absence of IFN-y within the graft may also contribute to prolongation of graft survival in an other way apart from the postulated effect on MHC class II expression . IFN-y has been described as an activating agent for macrophages (54) , and the absence of the lymphokine in certain immune reactions has been associated with reduced macrophage infiltration and function (51) . We observed a lower percentage of macrophages within the intrarenally treated grafts ; concerning their function however, no direct data were obtained . It has been postulated that steroids interfere with macrophage function, e .g., inhibit the production of IL-1 and tumor necrosis factor (55, 56) . To what extent these mechanisms play an essential role during local immunosuppressive treatment has to be examined further .
We observed that high local drug levels of prednisolone did not affect the accumulation of activated (MHC class 11-positive) white cells within the graft, while the expression of IL-2-R on these cells was clearly inhibited . This obser-vation is in concordance to Gillis (17) , who demonstrated in vitro that steroids did not prevent cell activation but interfered with IL-2 production. Because IL-2-R expression is strongly induced by IL-2 (57), high local drug levels within the graft may interfere with IL-2-R expression by the inhibition of IL-2 production. The inhibition of IL-2-R expression may be an important mechanism to inhibit cellular immune response, as is suggested by immunosuppressive therapy with mAbs against the IL-2-R (58, 59).
In conclusion, intrarenal drug levels most likely did not affect the systemic immune responsiveness against the graft, since cellular infiltration in intrarenally treated grafts was hardly affected . Intrarenal drug levels, however, inhibited intragraft events such as IL-2-R expression, IFN-y production, and MHC class II induction on grafted tissue, and in this way prevented rejection. These data strongly support local independence of the cellular immune response within the graft after a certain time, as suggested by others . Second, the data indicate that local treatment of allografts can result in effective immunosuppression . Local manipulation of the immune response by steroids has proven successful in skin disease and inflammatory lung disease. Although the use of steroids in transplantation is also based on their andinflammatory effects, which may be of local as well as systemic origin (60), local delivery of the drugs to vascularized organ allografts has hardly been studied, since in man local steroid infusion into the renal artery of kidney transplants was seriously limited by infections and thrombosis (61, 62) . Recently, however, new types of oral drugs have been developed that allow selective treatment of target organs, e.g., liver or kidney, either by specific tissue binding of the drug or tissue-specific activation (63, 64) . The usefulness of immunosuppressive drugs that fulfill these pharmacologic properties has to be further examined .
Summary
In this report we investigated local regulatory mechanisms in graft rejection and their response to local immunosuppressive therapy. For this purpose local immunosuppression was induced in rat kidney allografts by intrarenal infusion of prednisolone . Intrarenal drug delivery resulted in high drug levels within the graft and low systemic drug levels . Systemic drug levels were by themselves not sufficiently immunosuppressive to induce graft survival, and local prednisolone levels within the graft proved to be responsible for prolongation of graft survival . During intrarenal drug delivery, systemic responsiveness to the renal allograft proved normal, since intrarenally treated grafts were infiltrated by MHC class II-positive host cells and, except for a somewhat lower percentage of macrophages, cellular infiltration in intrarenal treated grafts was comparable to untreated grafts . However, T cells and macrophages present in intrarenally treated grafts were not able to destroy the grafted tissue . Local immunosuppressive therapy resulted in inhibition of IL-2-R expression, absence of IFN-y, and prevention of MHC class II induction on grafted tissue . These observations strongly indicate the presence of local regulatory mechanisms in graft rejection. The experimental model described can be used for further analysis of these intragraft events . Moreover, the results demonstrate that local immunosuppres-sive therapy can contribute to effective inhibition of cellular immune response in graft rejection .
